Thrasos is a private, clinical-stage biotherapeutics company focused on delivering new solutions to individuals affected by kidney disease. There are currently few available therapies to treat and prevent the severe consequences of this disease, which affects as much as 10 percent of the world's population.

from http://www.thrasos.com/

Publications show all

Thrasos Therapeutics has published 1 articles.

Patents show all

35Applications20Issued

Clinical Trials show all

1Phase 2

SEC Filings show all

D1